DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 55 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $346,249,603 | +26.8% | 1,395,605 | +22.6% | 0.74% | +33.4% |
| Q2 2023 | $273,127,680 | -21.1% | 1,138,032 | -17.2% | 0.55% | -26.0% |
| Q1 2023 | $346,369,499 | -12.4% | 1,374,264 | -7.7% | 0.75% | -15.8% |
| Q4 2022 | $395,249,396 | +7.9% | 1,489,147 | +5.0% | 0.89% | -2.2% |
| Q3 2022 | $366,374,000 | +6.5% | 1,418,469 | +4.6% | 0.91% | +11.4% |
| Q2 2022 | $343,913,000 | -13.0% | 1,356,549 | +0.7% | 0.82% | +1.7% |
| Q1 2022 | $395,185,000 | -8.7% | 1,347,237 | +2.4% | 0.80% | -2.9% |
| Q4 2021 | $432,706,000 | +7.6% | 1,315,167 | -0.4% | 0.83% | -1.3% |
| Q3 2021 | $402,010,000 | -2.4% | 1,320,489 | -14.0% | 0.84% | +0.8% |
| Q2 2021 | $411,995,000 | +16.0% | 1,535,231 | -2.7% | 0.83% | +8.9% |
| Q1 2021 | $355,107,000 | +3.5% | 1,577,695 | +2.2% | 0.76% | -1.9% |
| Q4 2020 | $342,991,000 | -11.1% | 1,544,018 | -13.8% | 0.78% | -20.2% |
| Q3 2020 | $385,780,000 | +14.3% | 1,791,577 | -6.2% | 0.98% | +6.2% |
| Q2 2020 | $337,646,000 | +15.0% | 1,909,436 | -10.0% | 0.92% | -6.6% |
| Q1 2020 | $293,716,000 | -9.7% | 2,122,084 | +0.1% | 0.98% | +14.3% |
| Q4 2019 | $325,424,000 | – | 2,120,306 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
| Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
| Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
| CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
| MIROVA | 128,368 | $16,947,000 | 9.18% |
| Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
| Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
| Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
| Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |